1. 3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics
   Marcel Alexander Heinrich et al, 2019, Advanced Materials CrossRef
2. Promising Modulatory Effects of Cenicriviroc on the Progression of Mouse Colorectal Cancer through Inhibition of CCR2_CCL2 Signaling Pathway
   Mina Eslami et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression
   Thomas S. van Solinge et al, 2020, Frontiers in Molecular Biosciences CrossRef
4. Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies
   Alessio Ardizzone et al, 2023, Cells CrossRef
5. Human telomerase reverse transcriptase recruits the β-catenin/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer
   Siyuan Chen et al, 2019, Biomedicine & Pharmacotherapy CrossRef
6. Tumor‐associated macrophages as treatment targets in glioma
   Yichen Peng et al, 2020, Brain Science Advances CrossRef
7. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing
   Fan Fan et al, 2021, Cellular Oncology CrossRef
8. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma
   Renwang Liu et al, 2023, Frontiers in Immunology CrossRef
9. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
   Ji’an Yang et al, 2020, Frontiers in Genetics CrossRef
10. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
    Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef
11. MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2
    Chao Yang et al, 2021, Cell Death & Disease CrossRef
12. Diosmin Inhibits Glioblastoma Growth through Inhibition of Autophagic Flux
    Yung-Lung Chang et al, 2021, International Journal of Molecular Sciences CrossRef
13. Levetiracetam, an Antiepileptic Drug has Neuroprotective Effects on Intracranial Hemorrhage Injury
    Takahiko Imai et al, 2020, Neuroscience CrossRef
14. Third Ventricular Injection of CCL2 in Rat Embryo Stimulates CCL2/CCR2 Neuroimmune System in Neuroepithelial Radial Glia Progenitor Cells: Relation to Sexually Dimorphic, Stimulatory Effects on Peptide Neurons in Lateral Hypothalamus
    Guo-Qing Chang et al, 2020, Neuroscience CrossRef
15. Chemokine receptor antagonists as immunotherapy agents and adjuncts for glioblastoma
    Adela Wu et al, 2022, Immunotherapeutic Strategies for the Treatment of Glioma CrossRef
16. CCL2 activates AKT signaling to promote glycolysis and chemoresistance in glioma cells
    Yafang Qian et al, 2022, Cell Biology International CrossRef
17. Gold nanoparticles enhances radiosensitivity in glioma cells by inhibiting TRAF6/NF-κB induced CCL2 expression
    Hao Wang et al, 2023, Heliyon CrossRef
18. MicroRNA‑6852 suppresses glioma A172 cell proliferation and invasion by targeting LEF1
    Jialiang Wang et al, 2019, Experimental and Therapeutic Medicine CrossRef
19. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation
    Geun-Young Park et al, 2021, Cellular Oncology CrossRef
20. Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
    Eilam Yeini et al, 2021, Advanced Therapeutics CrossRef